TickerFacts.

Quest Diagnostics Inc (DGX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$7.21B
As of 2025-12-31
$7.82B
As of 2026-06-30
+6.7%
3-year compound annual growth
+1.1%
5-year compound annual growth
+4.3%
10-year compound annual growth
2007-12-31: $3.35B2008-12-31: $3.63B2009-12-31: $4.01B2010-12-31: $4.05B2011-12-31: $3.71B2012-12-31: $4.19B2013-12-31: $3.97B2014-12-31: $4.33B2015-12-31: $4.71B2016-12-31: $4.66B2017-12-31: $4.96B2018-12-31: $5.27B2019-12-31: $5.69B2020-12-31: $6.81B2021-12-31: $6.48B2022-12-31: $5.93B2023-12-31: $6.34B2024-12-31: $6.81B2025-12-31: $7.21B$7.21B
2007-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$7.21B+5.8%2026-02-26, Balance as of period end
2024-12-31$6.81B+7.4%2026-02-26, Balance as of period end
2023-12-31$6.34B+6.9%2026-02-26, Balance as of period end
2022-12-31$5.93B-8.5%2025-02-20, Balance as of period end
2021-12-31$6.48B-4.8%2024-02-22, Balance as of period end
2020-12-31$6.81B+19.7%2023-02-21, Balance as of period end
2019-12-31$5.69B+8.0%2022-02-28, Balance as of period end
2018-12-31$5.27B+6.3%2021-02-22, Balance as of period end
2017-12-31$4.96B+6.3%2020-02-20, Balance as of period end
2016-12-31$4.66B-1.1%2019-02-21, Balance as of period end
2015-12-31$4.71B+8.8%2018-02-23, Balance as of period end
2014-12-31$4.33B+9.0%2017-02-22, Balance as of period end
2013-12-31$3.97B-5.1%2016-02-26, Balance as of period end
2012-12-31$4.19B+12.7%2015-02-24, Balance as of period end
2011-12-31$3.71B-8.4%2014-02-18, Balance as of period end
2010-12-31$4.05B+1.1%2013-02-27, Balance as of period end
2009-12-31$4.01B+10.7%2012-02-16, Balance as of period end
2008-12-31$3.63B+8.4%2011-02-16, Balance as of period end
2007-12-31$3.35Bn/a2010-02-17, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Quest Diagnostics Inc (DGX)2025-12-31$7.21B+5.8%
Labcorp Holdings Inc. (LH)2025-12-31$8.62B+7.0%
Fortrea Holdings Inc. (FTRE)2025-12-31$563.50M-58.6%
Natera, Inc. (NTRA)2025-12-31$1.71B+43.2%
RadNet, Inc. (RDNT)2025-12-31$1.36B+19.6%
Guardant Health, Inc. (GH)2025-12-31-$99.31Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$577.31Mn/m
Veracyte, Inc. (VCYT)2025-12-31$1.31B+11.4%
CareDx, Inc. (CDNA)2025-12-31$303.10M-19.9%

Compare DGX, LH, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗